Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:alkaloid |
| gptkbp:administeredBy |
oral
topical intravenous |
| gptkbp:CASNumber |
57-47-6
|
| gptkbp:discoveredBy |
gptkb:Jobst_and_Hesse
|
| gptkbp:discoveredIn |
1864
|
| gptkbp:effect |
increases acetylcholine levels
|
| gptkbp:foundIn |
gptkb:Physostigma_venenosum
|
| gptkbp:hasMolecularFormula |
C15H21N3O2
|
| gptkbp:otherName |
gptkb:physostigmine
|
| gptkbp:sideEffect |
nausea
muscle cramps bradycardia |
| gptkbp:usedAs |
gptkb:acetylcholinesterase_inhibitor
|
| gptkbp:usedFor |
treatment of glaucoma
treatment of myasthenia gravis |
| gptkbp:bfsParent |
gptkb:Physostigmine
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
eserine
|